Related Experiment Videos
Glucocorticoid antagonists as probes to study the vascular effects of glucocorticoids
1INSERM U 90, Hôpital Necker, Paris, France.
Kidney International. Supplement
|October 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
18F-FDG PET/CT images defined the true extent of a urothelial bladder carcinoma.
Urology case reports·2020
Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.
Current oncology (Toronto, Ont.)·2017
Arterial remodelling in Fabry disease.
Acta paediatrica (Oslo, Norway : 1992). Supplement·2003
[Clinical genetics at the crossroads: the example of hereditary kidney diseases].
Bulletin et memoires de l'Academie royale de medecine de Belgique·2002
[Progressive renal failure caused by lithium nephropathy].
Presse medicale (Paris, France : 1983)·2002
Effect of kidney disease on glucose handling (including genetic defects).
Kidney international. Supplement·2011
Need for better diabetes treatment for improved renal outcome.
Kidney international. Supplement·2011
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.
Kidney international. Supplement·2011
SGLT2 inhibitors: molecular design and potential differences in effect.
Kidney international. Supplement·2011
Glucose handling by the kidney.
Kidney international. Supplement·2011
Bone: from a reservoir of minerals to a regulator of energy metabolism.
Kidney international. Supplement·2011
Distinct polyamine effects on Candida albicans morphogenesis identify spermidine as a key regulator.
Microbiology spectrum·2026
Immunogenicity of locally acting large molecule products: An overview.
Journal of clinical pharmacology·2026
Antiplasmodial Activity and Safety Evaluation of Three Widely Distributed Polyherbal Antimalarials in Ghana.
Journal of tropical medicine·2026
Chemical basis for arginine citrullination by human PAD4.
Chemical communications (Cambridge, England)·2026